Massive 4000-Patient study launched to map rare liver disease in china
NCT ID NCT07149675
Summary
This study aims to better understand primary biliary cholangitis (PBC), a chronic autoimmune liver disease, in China. Researchers will follow 4,000 patients from multiple hospitals to track their symptoms, treatments, and long-term health outcomes. The goal is to gather detailed information to help doctors improve future care for people with this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS (PBC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Liver Research Center, Beijing Friendship Hospital, Capital Medical University
RECRUITINGBeijing, Select A State Or Province, 100069, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.